Jin Sung Lee (Jin-Sung Lee)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 7

Top Topics

Circulating Tumor Cells

Dna Methylation

Low Birth Weight

Top Venues

Yonsei medical journal

Journal of Korean medical science

This page only lists publications with an associated author ORCID identifier.

Publications

Ji Young Oh, Jin Sung Lee, Moo Suk Park, Young Ae Kang, Hyung-Ju Cho, Song Yee Kim, Jinsei Jung, Sun Och Yoon, Kyung Won Kim
Diagnosis of Primary Ciliary Dyskinesia via Whole Exome Sequencing and Histologic Findings. Yonsei medical journal 65 (1) (2024)
Ji Young Oh, Jin Sung Lee, Moo Suk Park, Young Ae Kang, Hyung-Ju Cho, Song Yee Kim, Jinsei Jung, Sun Och Yoon, Kyung Won Kim
Diagnosis of Primary Ciliary Dyskinesia via Whole Exome Sequencing and Histologic Findings. Yonsei medical journal 65 (1) (2024)
Ji Young Oh, Jin Sung Lee, Moo Suk Park, Young Ae Kang, Hyung-Ju Cho, Song Yee Kim, Jinsei Jung, Sun Och Yoon, Kyung Won Kim
Diagnosis of Primary Ciliary Dyskinesia via Whole Exome Sequencing and Histologic Findings. Yonsei medical journal 65 (1) (2024)
Ji Young Oh, Jin Sung Lee, Moo Suk Park, Young Ae Kang, Hyung-Ju Cho, Song Yee Kim, Jinsei Jung, Sun Och Yoon, Kyung Won Kim
Diagnosis of Primary Ciliary Dyskinesia via Whole Exome Sequencing and Histologic Findings. Yonsei medical journal 65 (1) (2024)
Byuh Ree Kim, Jeong Ho Han, Jeong Eun Shin, Min Soo Park, Kook In Park, Ran Namgung, Hyun Joo Lee, Jin Sung Lee, Ho Seon Eun
Genitopatellar Syndrome Secondary to De Novo KAT6B Mutation: The First Genetically Confirmed Case in South Korea. Yonsei medical journal 60 (4) (2019)
Hyun Joo Lee, Joo Hee Lim, Jeong Eun Shin, Ho Seon Eun, Min Soo Park, Kook In Park, Ran Namgung, Jin Sung Lee
Implementation of a Targeted Next-Generation Sequencing Panel for Constitutional Newborn Screening in High-Risk Neonates. Yonsei medical journal 60 (11) (2019)
Jin Ho Choi, Beom-Hee Lee, Jung Min Ko, Young Bae Sohn, Jin Sung Lee, Gu Hwan Kim, Sun Hee Heo, June-Young Park, Yoo-Mi Kim, Ja-Hye Kim, Han Wook Yoo
A phase 2 multi-center, open-label, switch-over trial to evaluate the safety and efficacy of Abcertin® in patients with type 1 Gaucher disease. Journal of Korean medical science 30 (4) (2015)